Latest Industry Insights

Technology Networks spoke with Arvind Kothandaraman to find out about the technologies underpinning syndromic testing, recent advances in the field and its possible role in pandemic prevention.

This article discusses the importance of data lineage and traceability for academic labs looking to maximize their publishing potential.

This article discusses how specialized charge detection mass spectrometers have been developed to enable simultaneous charge detection and decipher large and complex macromolecules, ultimately increasing accuracy and providing high-resolution measurements for better analysis of biotherapeutics.

There is widespread concern about the characteristics of PFAS and its impacts on human health. Can a protein biosensor help in this fight?

To understand how machine learning methods and new software capabilities are helping proteomics researchers gain greater depth in their analyses, Technology Networks recently interviewed Tharan Srikumar, product manager in bioinformatics at Bruker Daltonics.

Technology Networks spoke to Dr. Cenk Sumen, chief scientific officer of MaxCyte, about their pioneering cell engineering platform.

Developing and manufacturing biotherapeutics at scale requires thorough analysis of the active substance’s characteristics to ensure it fulfils both efficacy and safety requirements. Analytical technologies, such as mass spectrometry, are key tools adopted in this process.

Despite hydrogen being used successfully in many labs, concerns persist about converting existing helium-based methods to hydrogen. We speak to Aaron Boice from Agilent to learn how a new technology is helping with this transition.

In this interview, we spoke to Rachel Marty Pyke PhD, manager of bioinformatics science at Personalis, to find out how machine learning can be used to detect genomic instability as a biomarker for cancer immunotherapy.

The science and medicine worlds are experiencing a new revolution, and this time the protagonist is the mRNA molecule. In this article, we explore why bioplatforms support this revolution.